炎症
癌症研究
促炎细胞因子
转录因子
生物
癌基因
氧化应激
细胞因子
免疫学
细胞
细胞周期
生物化学
基因
作者
Huanhuan Ma,Tingyan Cao,Fengqiong Zhang,Dachao Sun,Lili Chen,Yao Lin,SW Lai,Bin Jiang,Yanming Zhou,Jun A You,Xiyao Liu,Yue Wang,Furong Lin,Yuxin Liu,Jinyang Wang,Weiling He,Qinxi Li
出处
期刊:Gut
[BMJ]
日期:2025-06-27
卷期号:: gutjnl-2024
被引量:2
标识
DOI:10.1136/gutjnl-2024-334087
摘要
Background Chronic inflammation and elevated reactive oxygen species are key contributors to hepatocellular carcinoma (HCC) progression. Objective This study aims to investigate the role of the oxidative stress sensor protein Pirin (PIR) as a critical mediator of inflammation in HCC progression. Design We investigated PIR’s role in HCC tumourigenesis through RNA interference, genetic knockout and pharmaceutical inhibition in HCC cell lines and various mouse models. Furthermore, we used transcriptomics, quantitative reverse transcription PCR, western blot, immunofluorescence staining and immunohistochemistry analysis to elucidate the molecular details. Results This study reveals a novel redox-dependent mechanism governing PIR’s nuclear shuttling, contributing to liver inflammation and HCC progression. We identified a positive feedback axis where nuclear PIR amplifies inflammatory responses, leading to hepatitis and HCC advancement. Cytokines in this loop are regulated by PIR-enhanced v-rel reticuloendotheliosis viral oncogene homolog A (RELA) transcription, promoting PIR’s nuclear translocation, increasing proinflammatory cytokine levels, and disrupting redox balance. We confirmed that liver parenchymal cells produce autocrine cytokines supporting their growth and malignancy. Notably, PIR’s redox-mediated nuclear shift can be inhibited by N-acetyl cysteine or PIR inhibitors, reducing HCC promotion in mice. Conclusion We elucidate a novel redox-dependent regulatory mechanism governing the nuclear localisation of PIR and its role in promoting liver inflammation and HCC progression. Our findings underscore the significance of cellular redox status in regulating PIR’s activity and highlight the potential of targeting this pathway with antioxidants to mitigate HCC progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI